AIM
CNMD icon

Acrospire Investment Management’s CONMED CNMD Stock Holding History

Acrospire Investment Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,600
Closed -$82K – 300
2017
Q2 		$82K Buy
+1,600
New +$79.2K 0.08% 377
2016
Q2 		– Sell
-406
Closed -$17K – 2047
2016
Q1 		$17K Buy
+406
New +$15.9K 0.01% 1585

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Acrospire Investment Management's CNMD Position: Q3 2017 in Review

Acrospire Investment Management sold out of CONMED (CNMD) in Q3 2017, closing a stake of 1,600 shares — an estimated $82K sold.

Acrospire Investment Management first reported a position in CNMD in Q1 2016 and held it in 2 quarters. The position peaked at $82K in Q2 2017. 144 funds tracked by Wall St. Rank hold CNMD as of Q3 2017.

  • Acrospire Investment Management reported no remaining CONMED position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,600 CONMED shares in Q3 2017, an estimated $82K.
  • Acrospire Investment Management first reported a position in CONMED in Q1 2016 and held it in 2 quarters.
  • Acrospire Investment Management's CONMED position peaked at $82K in Q2 2017.
  • 144 funds tracked by Wall St. Rank held CONMED as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.